VEGA Prospective Kiel

Rheumatoid Arthritis Clinical Trial

Official title: A Prospective Observational 5 Year Follow-up on a Historical Consecutive Cohort of 100 Primary Total Knee Arthroplasty (TKA) Cases Treated With the Posterior-stabilized VEGA System® PS

Status Completed

Clinical Trial Summary

Voluntary Post-Marketing Clinical Follow-up (PMCF) as part of the post marketing surveillance plan for the product under investigation.

For this PMCF only CE-marked medical devices have been used and will be used within their intended purpose and no additional invasive or other stressful examinations have been or are to be carried out (acc. to MPG §23b).

Clinical Trial Description

This non-interventional clinical study (NIS) is conducted to clinically confirm the safety and performance of the Aesculap® VEGA System® PS components under routine conditions. The VEGA System® PS is an established TKA design, and there is a long-lasting experience in the use of PS components in particular; thus a NIS is thought to be sufficient to give the required confirmation. For this NIS only CE-marked medical devices have been used and will be used within their intended purpose and no additional invasive or other stressful examinations have been and are to be carried out (acc. to MPG §23b). This voluntary NIS is part of the post-marketing surveillance for the product under investigation. ;

Related Conditions & MeSH terms

• Arthritis, Rheumatoid
• Degenerative Osteoarthritis
• Osteoarthritis
• Rheumatoid Arthritis

• NCT number: NCT02802085
• Study type: Observational
• Source: Aesculap AG
• Status: Completed
• Start date: May 2016
• Completion date: February 2018